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Introduction"
Periodontal disease is a world wide health problem. It is comprised of a
family of closely related acute and chronic inflammatory disorders affecting the
tissues housing the teeth. [1] Although a substantial research effort has been
devoted to studying the etiology, progression, and treatment of periodontal
diseases, there remains uncertainty regarding the specific processes resulting
in the expression of aspects of periodontal disease, including the
pathogenesis of periodontitis.
Periodontal disease involves the same immunological responses and
inflammatory mediators as those described for many other common
inflammatory disease processes. Similar to the multitude of diseases we
continue to confront in modern medicine, periodontal disease poses many
unanswered questions. Many of these questions pertain to the nature of
disease causation and the specific biological consequences of variables
believed to play a role in periodontal disease expression.
As stated in the 1989 Proceedings of the World Workshop in Clinical
Periodontics, the treatment of inflammatory periodontal disease has several
major therapeutic goals,
The immediate goal is to prevent, arrest, control, or eliminate
periodontal disease. The ideal goal would be to promote heal-
ing through regeneration of lost form, function, esthetics, and
comfort. When the ideal cannot be achieved, the pragmatic goal
of therapy would be to repair the damage resulting from disease.
The ultimate goal of therapy is to sustain the masticatory
apparatus- especially teeth or their analogues, in a state of
health. [2]
Clearly, this statement demonstrates the essence of the current goals of
periodontal treatment; namely, maintaining a healthy periodontium, while
halting destructive disease processes. An understanding of the complexities of
the disease process is essential to satisfy these goals.
The essential role of periodontal pathogens in promoting both
inflammatory disease (gingivitis) and destructive disease (periodontitis) is well
established. However, what is less well understood is the complex array of
interrelationships that exist among microorganisms and the host cells in such
disease processes. As Roy C. Page noted, "The aetiology of inflammatory
periodontal diseases can be considered in terms of the microorganisms
involved, the local environmental factors other than bacteria, and the role
played by the host defence systems" [1]. Over the past decade, advances in our
understanding of periodontal disease etiology and progression have been
enormous. Such progress has enabled periodontists to better understand
therapeutic interventions in treating and preventing disease. However, critical
issues regarding disease pathogenesis remain uncertain.
Gingivitis: Gingival Inflammatory Disease
Bacteria are a primary etiologic causative agent in inflammatory
periodontal diseases [1]. Gingivitis is defined as inflammation of the gingiva
and is the initial form of periodontal disease [3]. It precedes the destructive
lesion that characterizes periodontitis [4]. Gingivitis is initiated following the
accumulation of microbial plaque on and near the cervical region of the teeth
and its apical extension along the root surface [1, 5]. Bacterial plaque has been
shown to be the sole identifiable etiologic factor in gingival inflammation of
humans [6]. Numerous studies demonstrate the complexity of microorganisms
that compose the subgingival periodontal flora [7-13]. What is well accepted is
that a shift from health to gingivitis is characterized microbiologically by a
change from a gram-positive, predominantly non-motile streptococcal
subgingival microflora to a more complex flora including gram-negative and
spiral forms [1, 11, 14].
The initiation of gingivitis is multifactorial. According to a 1992 publication
by Genco, indirect mechanisms (host responses) combine with direct
mechanisms (bacteria and their products) to determine the intensity of the
inflammatory reaction in gingival tissue [15]. The importance of the host derived
factors can be demonstrated by the multitude of mediators found in gingival
crevicular fluid (GCF). These have been identified and studied in order to
determine their role in the pathogenesis of inflammatory periodontal disease.
Caffesse and Nasjleti suggested a role for hyaluronidase as a promoter for
bacterial collagenase penetration through intact gingival epithelium [16]. In a
1990 publication, Kunimatsu and coworkers noted activities similar to
cathepsins B,D,H, and L present in inflamed gingival tissue and in GCF from
inflamed sites [17]. Finally, neutral proteases resembling elastase, trypsin,
chymotrypsin, and other factors have been recovered in GCF from inflamed
sites [18], as have the cytokines IL-1 alpha and IL-1 beta [19], prostaglandin E2
(PGE2) and a number of enzymes which are believed to play a role as important
proinflammatory mediators. In fact, the presence of prostaglandins, specifically
PGE2 in gingival crevicular fluid or corresponding tissue samples, correlates
directly with the severity of gingival inflammation in the adjacent tissues [20].
While an understanding of the biological consequences of host derived
factors is essential for a thorough understanding of the nature of disease
progression, the role of pathogenic bacteria, bacterial products, and the
resultant host response should be underscored. The inflammatory reaction or
series of reactions are "classic" and involve all inflammatory and immune cells
and cell products, as the various stages of inflammation progress. With the
initial accumulation of plaque, bacteria and/or their products adhere to or
penetrate tissue and thereby induce a host response through activation of
complement and the migration of PMNs [21]. As inflammation progresses,
antibodies and cytokines increase in level. When bound to bacteria, antibodies
promote complement binding and thereby stimulate phagocytes to engulf
bacteria [22]. Complement is activated by antigen- antibody reactions and
through the alternate pathway by various bacterial components [23]. One of
many bacterial components, lipopolysaccharide (LPS), is believed to play a
primary role in the pathogenesis of the destructive lesion that characterizes
periodontal disease [24, 25]. A series of enzymatic reactions then occur that
result in the release of C3a and C5a, which influence mass cell degranulation,
histamine release, and thereby an increase in vascular permeability. This series
of biological reactions, combined with leukocyte migration, results in stasis and
inflammatory exudate from vessels [15]. Both C3a and C5a, as well as the
bacterial product FMLP act as chemoattractants for neutrophils [26]. Once
stimulated, neutrophils release products which mediate damage to host tissues
[27].
Gingivitis" Experimental Histopathology
In 1968, Thilander employed transmission electron microscopy in order
to study gingival biopsies from 12 gingivitis patients, and noted that crevicular
epithelium may become more permeable as inflammation progresses. The
author recognized slight changes characterized by vessel dilation, focal edema,
and increased epithelial spaces; moderate changes; and marked changes
suggestive of structural degeneration of the gingival apparatus [28].
In 1976, Page and Schroeder proposed a model that is consistent with
the pathogenesis of gingival inflammatory disease, as described [4]. According
to the authors, the histopathologic lesion of gingivitis may be described as
initial, early, and established. The "initial" lesion is a histological entity that
correlates with preclinical gingivitis. In humans it is seen within about four days
of the beginning of plaque accumulation [1]. During this initial stage, the
changes are subtle. They may be detected in the junctional epithelium and
perivascular connective tissue. There is an increase in the migration of
leukocytes which accumulate within the gingival sulcus and this can be
correlated with an increase in the flow of gingival fluid to the sulcus [29]. Other
findings include vasculitis of the vessels adjacent to the junctional epithelium
and gingival sulcus; presence of extracellular serum proteins, especially fibrin,
alteration of the most coronal portion of the junctional epithelium, and loss of
perivascular collagen [4]. The nature and character of the host response
determines whether this lesion resolves rapidly or evolves into a chronic
inflammatory lesion. If a chronic lesion evolves, an infiltrate of macrophages
and lymphoid cells appears within a few days [30].
The "early’ lesion correlates clinically with early gingivitis and appears 4
to 7 days following plaque accumulation. It is most notably characterized by a
dense lymphoid infiltrate. Collagen loss increases and lymphoid cells
accumulate and comprise approximately 75% of the infiltrate present.
Specifically, during the early lesion a histological examination of the gingiva
reveals a predominantly lymphocytic infiltration in the connective tissue
proximal to the junctional epithelium. Neutrophils, macrophages, plasma cells
and mast cells may also be present. The overall inflammatory cell response is
intensified relative to the initial lesion [31-35]. There is an increase in collagen
destruction, and alterations in blood vessel morphologic features and vascular
bed patterns are evident [36]. PMNs are found at increased levels in the
epithelium and emerging in the pocket area. Researchers note PMN attraction
to bacteria, phagocytosis and subsequent release of lysosomes [32].
The "established’ lesion correlates with chronic adult gingivitis. It occurs
2 to 3 weeks after the onset of plaque accumulation. The primary histo-
pathologic feature of the established lesion is the presence of plasma cells.
The lesion is characterized by the predominance of IgG and to a lesser degree
by IgA and IgM. Blood vessels become engorged and congested, venous return
is impaired and blood flow becomes sluggish [3]. The result is localized gingival
hypoxemia. Extravasation of red blood cells into the connective tissue and the
breakdown of hemoglobin may influence the clinical presentation of the gingiva
[3]. Histologically, continued loss of connective tissue is noted, and plasma cells
predominate without an appreciable loss of bone. Plasma cells invade the
connective tissue not only immediately apical to the junctional epithelium, but
also deep into the connective tissue, around blood vessels, and between
bundles of collagen fibers. The junctional epithelium reveals widened
intercellular spaces filled with granular cellular debris, including lysosomes
derived from disrupted neutrophils, lymphocytes, and monocytes. In the
connective tissue, collagen fibers are destroyed around the infiltrate of intact
and disrupted plasma cells, neutrophils, lymphocytes, monocytes, and mast
cells [37]. Established lesions of two types appear to exist; namely, those that
remain stable and do not progress for several months or years and those that
appear to become more active and convert to a progressive destructive lesion
[1]. The nature of this conversion has been studied; however, it remains to be
completely understood [38].
Periodontitis: Destructive Periodontal Lesion
Clinically, periodontitis may be characterized by periodontal pocket
formation, suppuration, tooth mobility and alveolar bone destruction. However,
the adult periodontitis lesion resembles the established lesion of gingivitis as
described by Page (1976), with the additional "spread" of inflammation into the
surrounding tissues and the development of attachment loss characterized by
alveolar bone loss and periodontal pocket formation.
According to a 1976 publication entitled "Pathogenesis of inflammatory
periodontal disease, A summary of current work", the following characterizes
the histopathologic features of periodontitis" Predominance of plasma cells,
continuing loss of collagen subjacent to the pocket epithelium, formation of
periodontal pockets, presence of altered plasma cells in the absence of altered
fibroblasts, extension of the lesion into bone and PDL with obvious loss of bone,
and widespread manifestation of inflammatory and immunopathologic tissue
reaction [4].
Histological examination reveals that pocket development between the
tooth surface and the gingiva, with apical displacement of the junctional
epithelium (JE), is the first indication of destructive disease [39]. Muller-Glauser
and Schroeder (1982) recognized thickening of the epithelium and rete ridge
development following replacement of the JE by pocket epithelium [40]. Micro-
ulceration of the pocket epithelium may occur and allow penetration of bacteria
and/or bacterial products. Such penetration may lead to a burst of disease
activity [39]. According to Takata and Donath, the initial JE defect is located
within the JE, as opposed to the JE/tooth interface [41]. A JE will develop, as
the pocket epithelium grows down the connective tissue/tooth interface.
Irreversible change, characterizing the periodontal destructive lesion, occurs as
the epithelium along the cementum/soft tissue interface prevents the
establishment of connective tissue reattachment [39].
Gingivitis (gingival inflammatory lesion) does not necessarily progress to
periodontitis (destructive periodontal lesion) and predicting which sites will
demonstrate clinical and or radiographic evidence of breakdown is difficult.
While gingivitis lesions may be transient or persistent, most are not progressive.
However, a small percentage can and do progress to periodontitis. While a
number of methods, including drug tests, sensitivity testing and a host of clinical
criteria may be employed to identify sites that may be at risk for breakdown, the
sensitivity and specificity of these tests do not consistently predict which sites
progress from inflammatory to destructive lesions. Ranney in a 1986
publication suggested that histologically, gingivitis has not been ruled out as a
necessary precursor to periodontitis, but it does not invariably progress to
periodontitis. Ranney suggests certain measures of host responses as
predictors of such a conversion [42].
It is important to recognize that additional variables play an important
role in our understanding of periodontitis and the progression of gingivitis to
periodontitis as described. For example, in a 1975 study by Lindhe and
coworkers entitled, "Plaque induced periodontal disease in beagle dogs", the
authors found that periodontitis might be prevented by calculus removal and
oral hygiene and that gingivitis can proceed to periodontitis. However, they
reported that in 2 of the 10 untreated animals some sites failed to progress to
periodontitis, suggesting a role for host susceptibility in the expression of
periodontitis. Such research lends support to the notion of a multifactorial basis
for periodontal disease establishment and its progression.
With a conversion to periodontitis, the subgingival flora at diseased sites
is predominantly gram-negative, anaerobic, and motile. While a host of
pathogens have been associated with changes that characterize destructive
periodontal lesions, those organisms which are most prevalent in adult
periodontitis include Porphyromonas gingivalis, Prevotella intermedia,
spirochetes, Eichenella and members of the genera Bacteroides and
Capnocytophaga. While the progression of adult periodontitis may be
associated with a characteristic microflora, and an association with clinical
attachment loss may implicate particular organisms in the pathogenesis of
periodontitis [43], the specific mechanisms by which these microorganisms and
their microbial products promote periodontal destruction remains surprisingly
controversial. Because bacterial invasion of gingival tissue is not a hallmark of
either gingivitis or periodontitis [37, 44], most believe that soluble microbial
products derived from subgingival organisms promote host inflammatory
reactions and destructive periodontal diseases [45, 46]. For example, Theilade
and coworkers demonstrated that the alteration in the proportion of bacteria in
plaque toward an increased percentage of gram negative microorganisms
paralleled the beginning of leukocyte migration into the gingiva [47]. Therefore,
it would appear that some substance produced by gram-negative organisms in
bacterial plaque causes the initial clinical and histologic signs of inflammation
that have been described [48].
Lipopolysaccharide (LPS)
LPS is a component of the cell wall of gram-negative bacteria and is
presumed to play a role in the changes associated with both inflammatory and
destructive periodontal disease processes [24, 25, 48-55]. The relationship of
LPS to the etiology of periodontal diseases is of interest when one considers
that LPS is a potent inflammatory agent. Because of its biological activity, LPS
is considered a primary pathogenic factor in inflammatory and destructive
processes. However, its precise role in inflammatory and destructive
periodontal disease pathogenesis is not entirely certain and therefore remains
controversial. For example, while the release of LPS from organisms within the
subgingival plaque has not been related to periodontal destructive processes, it
has been reported that LPS levels in gingival crevicular fluid have been
positively correlated with clinical and histologic signs of gingival inflammation
[48, 52].
Virtually all gram-negative periodontal pathogens possess
lipopolysaccharide (LPS) as a cell wall constituent [56]. The term endotoxin
describes a lipopolysaccharide component found on the outer membrane of the
cell wall of gram-negative bacteria. The term originates from early workers, such
as Pfeiffer (1892), who noted that "apart from the toxin released or shed into the
culture medium by living gram-negative microorganisms, exotoxin, additional
toxic substances were released coincident with the bacteria while undergoing
cellular lysis. It was believed that these substances were fixed to the bacterial
cell, hence the term endotoxin"[50].
LPS is known to be a potent toxin, and its injection into LPS-susceptible
animals produces fever, bone marrow suppression, white blood cell changes,
shock and death [57]. Injection of LPS into the skin or mucosa of a number of
animal species results in a local acute inflammatory reaction characterized by
increased vascular permeability, vasodilatation, accumulation of leukocytes,
and subsequent tissue damage[49, 54]. Drutz and Graybill (1978) reported that
30-60% of patients in the United States with gram- negative sepsis die despite
antibiotic therapy, possibly the result of the irreversible effects of LPS [58]. LPS
has the ability to activate the complement system, and thereby produces many
of its biological effects [59]. According to Garrison and coworkers, "These
responses have previously been used to compare the relative potencies of LPS
preparations; however, the capacity to elicit these pathologic responses may
not correlate with periodontal tissue destruction. Furthermore, LPS potencies
within these biological systems may not be related to the pathogenesis of
periodontal disease" [43].
As previously noted, bacterial plaque has been shown to be the sole
identifiable, etiologic factor for gingivitis in humans [6], and periodontitis in dogs
[60]. However, plaque microorganisms do not typically penetrate the gingival
tissue to any significant degree. As a result, cytotoxic and antigenic factors
derived from plaque micro- organisms diffuse into the tissue and thereby
produce those clinical and histological changes which characterize the
inflammatory lesion of gingivitis and the destructive changes of periodontitis
[45, 46, 50].
LPS and Gingival Inflammatory Disease
Many researchers have proposed that LPS has profound biological
influence. Bacterial LPS has been shown to stimulate macrophages to lyse
tumor target cells in vitro, involving direct cell to cell contact [61]. Ranney and
Montgomery found that endotoxin from Leptotrichia buccalis caused carbon
particle leakage from vessels of healthy gingiva. They concluded that LPS
likely penetrates the healthy crevicular epithelium to produce this effect and
therefore may be important in the early events of gingivitis [49]. Rizzo and
Mergenhagen conducted acute toxicity experiments in rabbit oral mucosa
following local inoculation of an endotoxin from an oral Veillonella organism.
The authors found that a single inoculation of 50 ug of this endotoxin resulted in
gross abscesses which persisted for up to 10 days. Additionally, inflammatory
lesions were accompanied by regional lymph node neutrophilic infiltration.
Finally, they found that a minimal dose of 1.0 ug of LPS produced a local
Schwartzman reaction, and an intramucosal inoculation of 1.0 ug of LPS
increased body temperature [54].
The effect of LPS on PMN migration and phagocytosis was examined by
Jensen and coworkers. LPS from Veillonella, when applied to the forearms of
human volunteers, produced an increase in both PMN migration and
phagocytic activity. According to Daly (1980), the authors concluded that the
increase in PMN migration observed during the experimental gingivitis studies
was due to the persistent irritation of capillaries by LPS [50, 62]. Additional
support for a possible role for LPS came from a 1967 investigation by
Mergenhagen. The author noted the potent toxicity of Veillonella LPS and
found raised serum antibody levels, to LPS prepared from Fusobacterium and
Vefllonella, in those patients with periodontitis [51].
LPS and Periodontal Destructive Lesions
LPS may play an important role in alveolar bone loss during periodontal
disease. The bone resorbing effect of LPS has been noted by a number of
investigators. In a 1970 publication by Hausmann et al., the authors
demonstrated that LPS stimulates the release of previously incorporated 4Ca
from fetal rat bone in tissue culture [63]. Millar et al. in a 1986 study of two
distinct isolates of LPS from Bacteroides gingivalis, demonstrated that both
isolates stimulated 45Ca release from prelabeled fetal rat bones and elicited a
30-40% reduction in collagen protein formation [64]. The authors concluded that
such findings may implicate LPS in alveolar bone loss associated with
periodontal disease. Raisz et al. demonstrated an interaction between
endotoxin and other factors thought to act as specific mediators of localized
bone resorption. They found that interaction between endotoxin and other bone
resorbing factors may produce unexpectedly large resorptive responses. Such
reactions may certainly be significant in the pathogenesis of bone loss in
periodontal disease [65]. Current research indicates that LPS may mediate its
effects on bone resorption through indirect mechanisms such as stimulation of
cytokine secretion from monocytes and macrophages with a resulting increase
in bone resorption by cytokines.
Inflammatory Mediators" Interleukin-1 and Prostaglandin- Role in
Periodontal Diseases
Periodontal diseases are characterized by both inflammatory and
destructive lesions. A number of mediators play specific roles in these
processes. As previously mentioned, both interleukin-1 (IL-1) and prostaglandin
(PG) play significant roles in periodontal disease presentation and
progression.
I1-1 can be produced by virtually all nucleated cell types, including all
members of the monocyte- macrophage lineage, B lymphocytes, natural killer
(NK) cells, T lymphocyte clones grown in cell culture, keratinocytes, dentritic
cells, astrocytes, fibroblasts, neutrophils, endothelial cells, and smooth muscle
cells [66]. Humans express 2 distinct molecular forms of IL-1, called IL-1 alpha
and IL-1 beta; each having similar biological activity and binding affinity to cell
surface receptors. Few tissues express IL-1 constitutively, while the majority of
cell types produce IL-1 only in response to external stimuli, such as bacterial
LPS. The principal effects of IL-1 alpha and beta are costimulation of antigen
presenting cells (APCs) and T cells, B cell proliferation and Ig production,
phagocyte activation, bone resoprtion, inflammation and fever, and
hematopoiesis [66].
The chronic inflammatory response associated with established gingivitis
or adult periodontitis results in elevated recovery of host derived soluble
mediators which include interleukins [67]. The predominant cell type recovered
in gingival connective tissue, regardless of the disease status, is the fibroblast
[68]. Gingival fibroblasts exposed to interleukin- 1 are capable of secreting
elevated levels of prostaglandin E2, [69], a process which may account for a
large percentage of the prostaglandin E2 recovered in diseased gingival tissue.
At periodontitis sites, bone resorptive and inhibitory cytokines (IL-1 alpha, L-1
beta and TNF-alpha) in gingival tissue samples reach levels of 0.3, 11.7, and
0.4 ng/ml, respectively. Tissue samples from clinically healthy sites exhibit much
lower levels of these cytokines (0.07, 3.1, and 0.03 ng/ml, respectively) [70].
The identification of other biologically active substances produced by
host tissue in response to periodontal infection provides a direct means of
elucidating the mechanisms by which infection leads to loss of supporting
connective tissue and bone [71]. Tissue levels of prostaglandin t::2 are elevated
in inflamed as compared to normal periodontal tissues. Therefore it has been
postulated that PGE2 plays a profound role in gingival and periodontal diseases
[71]. This idea is supported by the ability of PGE2 to modulate inflammatory
reactions, immune reactions and bone resorptive processes [72]. In addition,
PGE2 levels are increased in the connective tissue in adult periodontitis lesions
[73, 74].
The production of PGE2 in a biological system involves multiple steps.
Activation of inflammatory cells causes a local release of arachidonic acid from
the cells. Such activity is catalyzed by phospholipase A2. El Attar
demonstrated that inflamed periodontal tissue exhibits a substantial increase in
the level of free arachidonate [75]. This substance is metabolized oxidatively
via the cyclooxygenase pathway, and a potent bone resorbing hormone, PGE2,
is produced. PGE2 has been shown to stimulate bone resorption both in vitro
[76] and in vivo. [74] Goodson et al. in 1974 demonstrated that PGE2 is
elevated in periodontal lesions [74]. Additionally, Offenbacher and coworkers
demonstrated that PGE2 levels correlate with periods of periodontal disease
activity, is a relatively good diagnostic indicator of sites likely to demonstrate
tissue breakdown, and is recovered in elevated levels in crevicular fluid in direct
relation to PGE2 levels in the juxtaposed gingival tissues [20, 77].
Periodontal Therapy Rationale: Role of LPS
Clearly, much is known about the nature and characteristics of
periodontal disease. In addition, many of the treatment modalities and their
efficacy are well understood and accepted as effective modes of therapy.
Conventional treatment of periodontitis may take the form of scaling and root
planing (mechanical removal of bacterial products) and/or surgical therapy.
The clinical benefits of scaling and root planing are derived from the
removal of subgingival plaque and calculus and the disruption of the
subgingival microbial flora and therefore a delay in the repopulation of
pathogenic microbes [78]. The indications for conventional periodontal surgical
therapy include access for root debridement, elimination of pockets by removal
and/or recontouring of soft or osseous tissues, removal of diseased periodontal
tissues, correction of mucogingival defects and establishment of gingival
architecture to facilitate oral hygiene and improve treatment prognosis [3].
Demonstration of the therapeutic benefit of scaling and root planing is the
result of the research efforts of many individuals [55, 79, 80]. Aleo and
coworkers studied the in vitro attachment of human gingival fibroblast cells to
the root surface of periodontally involved teeth. The author found that the
portion of root exposed to the destructive disease process had little or no cell
attachment. However, on the remainder of the unaffected root, the cells
attached normally. They concluded that clinical success would depend upon
complete removal of toxic materials from diseased cementum or the removal of
the cementum itself [79]. Their studies have shown that the cementum of
periodontally involved teeth exposed to the disease process contains
lipopolysaccharide or endotoxin; the remaining or uninvolved cementum is free
of endotoxin [79]. According to Ramjord (1980), bacterial products are
incorporated into the root cementum of periodontally diseased teeth; thus,
removal of contaminated cementum is considered the ultimate goal of root
surface debridement [80]. In contrast, Adelson and coworkers (1980)
investigated whether cultured fibroblasts will grow on heat sterilized
periodontally exposed root surfaces and whether root planing affects this
growth. The authors found no difference in pattern of cell growth, cell migration,
or cytotoxic reaction between root planed and non-root planed areas [81].
Alternate Theory: The Role of Hydroxy Fatty Acids and their
Relationship to Periodontal Disease
The preceding investigations offer scientific data regarding the role and
influence of LPS in periodontal diseases. However, others believe that an
alternate lipid, previously overlooked, may play a critical role in periodontal
destructive lesions. Current research points to a role for bacterial derived
hydroxy fatty acids in periodontitis, to the exclusion of LPS [56, 82, 83]. The
following is a summary of this evidence.
The toxic component of LPS is lipid A [84]. Lipid A contains the
characteristic 3-hydroxy bacterial fatty acids [85], some of which occur in
mammalian lipids with the exception of 3-OH O:17:0. The 3-OH fatty acids of the
lipid A have been used as markers for detecting LPS in body fluids and other
specimens [86, 87]. Based upon the vast number of publications throughout the
past three decades, the periodontal community has apparently accepted that
LPS plays a prominent role in periodontal disease. However, the changes
associated with the onset of the gingival inflammatory lesion and the
subsequent progression to a destructive lesion of the periodontium, may be
incorrectly credited to LPS.
In a comparative study conducted by Lygre et al., samples of root
substance from healthy and periodontally diseased human teeth were analyzed
for fatty acids. The authors found that the content of the fatty acids C6:o, C6:,
C18:o and C8: in the superficial layer of the periodontally diseased teeth was
significantly higher than that of healthy teeth. In the inner layer of the teeth, they
found no difference. The authors conclude that their mass- spectrometric
detection of 3-OH fatty acids demonstrated the presence of lipid A in the root
substance of single periodontally diseased teeth [24].
In a study designed to assess the distribution of 3-hydroxy iC17:0 in
subgingival plaque and gingival tissue samples and the relationship to adult
periodontitis, Nichols found elevated levels of 3-hydroxy iC17:0 within gingival
tissue lipids from periodontitis samples compared with healthy or mildly
inflamed samples. However, the elevated recovery of 3-OH iC17:o in gingival
tissue could not be attributed to LPS, because the bacterial hydroxy fatty acid
was recovered primarily in complex lipids. This may indicate a role for 3-
hydroxy iC17:o containing lipids, other than LPS, in the pathogenesis of
periodontitis [56].
An understanding of the biological consequences of bacterial lipid
penetration into gingival tissues in adult periodontitis is essential to our
continued effort to define effective treatment modalities and to better predict
which areas are most likely to develop signs of disease. If bacterial lipid
penetration into gingival tissue is mechanistically linked to the expression of
adult periodontitis, the recovery of the bacterial lipid in gingival tissue should
directly correlate with alterations in host tissue behavior [83]. Are bacterial
lipids recoverable on tooth root surfaces and at what levels? Do such bacterial
lipids at these levels have biological effects on periodontal tissues, specifically
fibroblasts?
The primary objective of our study is to examine the distribution and
biological effects of bacterial lipids, other than LPS, recovered on diseased root
surfaces. Such biological effects could revolutionize approaches to periodontal
treatment. Specifically, they may enable us to critically evaluate our current
treatments and the fundamental principles which support such treatment
modalities
The present investigation seeks to define a role for such hydroxy fatty
acid containing lipids, other than LPS, in the pathogenesis of periodontitis.
Specifically, we will first define and quantify hydroxy fatty acids in lipids
recovered from periodontally diseased teeth and their corresponding plaque
samples prior to extraction. Secondly, we will quantify hydroxy fatty acids in
lipids recovered from diseased roots before and after thorough root planing and
scaling. These experimental trials are essential, as the relevant biological levels
of bacterially derived lipids must be estimated prior to initiating an assessment
of the effects of these lipids on cultured mammalian fibroblast cells. Because
the bacterial lipids of the type examined in the present study are virtually
insoluble in aqueous medium and these bacterial lipids are thought to gain
entry into periodontal tissues through novel cell presentation mechanism/s and
transport, the lipids recovered in our study must be provided to cells in culture
such that the physical environment mimics the tooth/plaque-tissue interface in
human periodontal tissues. Given our understanding of the predominance of
fibroblasts in gingival connective tissue, [68] their expected exposure to
bacterial lipids in diseased periodontal tissues, [56, 83] and their secretion of
impressive levels of PGE2, our final goal will assess the biological influence of
defined quantities of bacterial lipids by investigating their direct influence on
mammalian gingival fibroblast secretory function, cell growth and recovery.
Furthermore, we will examine the effect of interleukin-1 on prostaglandin
secretion from gingival fibroblasts after exposure to either P. gingivalis or
calculus lipids known to contain the hydroxy fatty acids of interest.
Study Objective"
Experiment 1"
To quantify hydroxy fatty acids in lipids recovered from
individual teeth and corresponding plaque samples taken from
around each tooth immediately prior to extraction. The results of such
experimental trials will help to define the specific fatty acid components present
in periodontally diseased root surfaces. Prior to initiating an assessment of the
bacterial lipid effects on gingival fibroblast cell recovery and function, the
relevant biological levels of these fatty acids must be determined. Moreover, by
determining the quantity of such fatty acids on both tooth surfaces and
corresponding plaque samples, we may develop an understanding of the
potential that may exist for selective adsorption of such bacterial products.
The application of phospholipid extraction procedures [88] to plaque and
tooth samples would be expected to separate bacterial lipids, recovered in the
organic solvent phase, from LPS, which remains in the aqueous phase.
Assuming that bacterial hydroxy fatty acids are not also synthesized in human
tissues, the recovery of covalently linked hydroxy fatty acids in aqueous and
organic extracts of biological samples should provide an indirect assessment of
the quantity of LPS- and lipid- associated hydroxy fatty acids. Of the common
bacterial hydroxy fatty acids, most can be synthesized in mammalian tissues
during either beta or alpha oxidation processes, although in different epimer
forms. However, previous reports have not demonstrated 3-hydroxy i017:0
synthesis in mammalian tissues exist. Therefore the recovery of 3-hydroxy i017:o
in organic solvent and aqueous extracts of biological samples should reflect the
2O
recovery of bacterial lipids or LPS, respectively, from those organisms
containing 3- hydroxy iC17:0.
A comparison of the percentage of this particular fatty acid present in the
complex lipids to that present in LPS, may support the notion that LPS is not a
primary causative factor. In fact, we hypothesize that it is not LPS, but rather 3
hydroxy iC17:o containing lipids, that are critical to periodontal destruction and
therefore to periodontal treatment success.
Methods and Materials"
Lipid Extraction and Separation"
Teeth destined for extraction were evaluated both clinically and
radiographically. Those teeth chosen demonstrated at least 50% bone loss
radiographically and clinical evidence of severe periodontitis. Plaque samples
from at least six aspects of each tooth were taken by placing course endodontic
paper points into the sulcus for 10 seconds and transferring the paper points to
glass tubes for processing. Teeth and plaque samples were immediately frozen
and processed by the phospholipid extraction procedure of Bligh and Dyer as
modified by Garbus [88, 89]. Water (0.5 ml) and 2 ml of CHCI3- methanol (1 "2
vol/vol) were added to each sample, and the samples were immediately
vortexed. After standing for at least 2 hours, 0.75 ml of CHCI3 and 0.75 ml of 0.5
M K2HPO4 and 2 M KCI were added to each sample and vortexed. The lower
CHCI3 phase, or lipid phase, was removed and dried under N2 gas. The
aqueous phase, expected to contain LPS, was retained, and the hydroxy fatty
acid content was analyzed by gas chromatography- mass spectrometry.
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Lipid Analysis by gas Chromatography-mass spectrometry:
All derivitizing agents were obtained from Pierce Chemical Corp.
(Rockford, III.). Nonadecanoic acid was added to each sample of LPS isolate or
lipid fraction. When alkaline hydrolysis was employed, the samples were
treated with 4N KOH (0.5 ml., 100 C, 90 min.), and the hydrolysate was
acidified with concentrated HCI. The acidified samples were then extracted with
CHCI3 (1 ml, three times) and the pooled extracts were dried under a stream of
N2 gas.The dried fatty acid samples were dissolved in acetonitrile (30ul) and
treated with 35% pentafluorobenzyl bromide in acetonitrile (10ul) and
diisopropylethylamine (10 ul). The solution was heated for 20 minutes at 40 C
and evaporated to dryness under N2 gas. The resultant pentafluorobenzyl
esters were treated with N-O-bis(trimethylsilyl)-trifluoroacetamide (50 ul) and
incubated overnight. The lipid derivatives were applied to a Hewlett Packard
model 5890 gas chromatograph interfaced with a model 5988A mass
spectrometer. Samples were applied to an Ultra-1 column (12mm x 0.2mm x
0.2um) held at 100 C. Samples were injected using the splitless mode and a
temperature program of 2 C per minute to 240 C. The mass spectrometer was
used in the negative-ion-chemical ionization mode with an ion source
temperature of 100 C, an electron energy of 240 eV, and an emission current
of 300 mA. Methane was used as the reagent gas and was maintained at
0.75 torr.
Known amounts of 2-hydroxy C4:o, C6:o, and C8:0 and 3-hydroxy C4:o,
C16:o, C17:o and C8:0 were analyzed for selected ion retention times and signal
responses relative to the internal standard (C19:o). Quantification of hydroxy fatty
acids from bacterial samples was accomplished by using selected ion
monitoring of the appropriate base peak ions, and extraction losses were
corrected by using the C19:o internal standard.
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Results
A comparison of the hydroxy fatty acid recoveries in organic extracts from
teeth and plaque samples is seen in Figure1. Statistically significant
differences regarding the percent of total fatty acid recovered in the organic
extract is evident for 3-OH C6:o (p=.0016), 3-OH C7:o (p=.0016) and 2-OH
C14:0 (p=.0321). The percentage of total fatty acid recovered in organic extract
differed between plaque and teeth samples for specific fatty acids. A greater
percent of 3-OH C6:0 was observed in lipids from plaque samples, than in
corresponding lipid extracts from teeth samples, while the opposite held true for
3-OH C17:O and 2-OH O14:O, where a greater percentage of fatty acid was
recovered in the organic extracts from teeth samples than in corresponding
plaque samples.
As is evident in Figure 1, the percent recovery of 3-OH C4.0 or 2-OH
C6:0 in organic solvent extracts was not significantly different when comparing
teeth with corresponding plaque samples.
With regard to 3-OH C7:0, approximately 60% of total fatty acid was
recovered in the organic extract, while the remaining fatty acid, presumed to be
incorporated into LPS, was present in the aqueous phase. A process of
selective adsorption may account for the elevated recovery of bacterial lipid
containing 3-OH C17:0 on root surfaces, when compared with 3-OH C17:o
containing lipid in plaque. This is consistent with a report by Nichols who noted,
"The fact that bacteria containing 3-hydroxy isobranched C17:0 are not
recovered in significant levels within diseased gingival tissue suggests that the
presence of periodontal microorganisms may have little bearing on the lipid
penetration process other than to provide the ceramide lipid for adsorption to
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root surfaces" [82]. The results presented in this thesis therefore support the
possibility of bacterial lipid adsorption to diseased tooth roots.
Experment 2:
To quantify hydroxy fatty acids in lipids recovered from
diseased roots before and after thorough root planing/ scaling. This
assessment determined the relevant levels of bacterial or calculus-tooth lipids
for testing in cultures of mammalian fibroblast cells.
It was our aim to quantify the amount of hydroxy fatty acids present in
both diseased and non-diseased root surfaces. Diseased root surfaces were
those which demonstrated gross calculus deposits by visual inspection, while
treated root surfaces were those which demonstrated a similar degree of
calculus prior to treatment consisting of thorough root planing and scaling.
Methods and Materials:
Teeth, extracted from one patient with a diagnosis of generalized severe
adult periodontitis, were frozen until processed. Prior to extraction,
approximately 15 plaque samples were taken from this same patient and
analyzed in the same manner described in goal one. Teeth were randomly
assigned either to a control group or to a scaling and root planing group. Using
a high speed handpiece, fifteen root sections with visible calculus were
prepared by making a cut parallel to the tooth surface. The sections were made
into the dentin approximately lmm in depth, careful not to include pulp tissues.
These root sections comprised the "diseased" sample group as previously
defined. Additional root surfaces where calculus was visibly evident were
scaled with an ultrasonic scaler and hand curettes. Each sample was treated
until all visible calculus was removed and the root surface appeared clinically
smooth. These root sections comprised the treated sample group. Each sample
within its appropriate group was handled and treated in the same manner.
Windows of these visibly cleaned root surfaces were sectioned in the identical
manner as the calculus "preserved" sites. Each of the 30 sections obtained
were photographed using a calibrated lens setting, followed by placement of
tooth sections into an individual glass tube for lipid extraction. The photographic
slides were then projected and paper tracings were cut to fit the root sections.
Additionally, a standard square was cut and photographed for increasing
surface areas (i.e. 2x2 mm2, 4x4 mm2, etc.). Each cutout of root slices and
surface area standards were weighed on a Metier balance and the surface area
of each root section was determined using a standard curve generated from
paper cutouts of known surface area. The surface area standards, between
surface area of paper cutout and weight, formed a perfect linear relationship.
Additional teeth contaminated with calculus were extracted in order to obtain a
sample of tooth/calculus lipid for biological testing.Porphyromonas gingivalis
was grown in pure culture and lyophilized and the dried bacterial pellet was
extracted for bacterial lipids. Subgingival plaque, tooth and root section
samples, as well as P. gingivalis (~ lmg) were extracted overnight using the
method of Bligh and Dyer, and as modified by Garbus.
Specifically, 0.5 ml of H20 + 2.0 ml of MeOH:CHCI3 (2"1 v/v) were added
to each sample vial and were shaken and vortexed. After 12 hours, 0.75 ml 2 N
KCI + 0.5 ml K2HPO4 + 0.75 ml CHCI3 were added to each sample and
vortexed. From each sample, the lower phase was carefully removed. An
additional 0.75 ml CHCI3 was added to each sample and vortexed. The lower
phase was removed and combined with the appropriate previously removed
organic extract. Each sample was dried under N2 gas followed by the addition
of 344 ug of OH:C19:0 (aqueous:organic). To each organic extract, 0.5 ul HCI
KOH was added followed by heating for 90 minutes at 95 C. Each of the
samples were then extracted twice with 2ul hexane. The hydroxy fatty acids
were then derivatized in order to make them volatile for analysis on the gas
spectrophotometer. (refer to pp. 21-22)
Recovery of bacterial hydroxy fatty acid in lipid extracts of unscaled and
scaled root sections were calculated per unit surface area (ng 3-OH
isoC7:o/mm2). These values were then averaged for the untreated and scaled
teeth. Using the recovery of 3-OH isoC17:o/ug in lipid extract of P. gingivalis (ng
3-OH isoC7:0/ug of P. gingivalis lipid), the mass of P. gingivalis to apply to 35
mm culture wells was calculated. The calculation of the equivalent amount of P.
gingivalis lipid needed in each culture well amounted to approximately 170 ug.
This value applies only to untreated root surfaces. This value was considered to
be an excessive amount of lipid for biological testing and therefore as a starting
values we chose to apply 10ug or 50ug of lipid to each culture dish well as
described, for our additional experiments. Hence, the value chosen was lower
than the maximum value calculated. The lipid extract of P. gingivalis was
dissolved in ethanol at the appropriate dilution and 20 ul of lipid solution was
deposited into each culture well and allowed to dry overnight, while maintained
in a laminar flow hood.
Recovery of 3-OH isoC17:0 in lipid extracts from cleaned root surfaces (ng
3-OH isoC17:o mm2) was used to determine the level of calculus- tooth lipid
extract to apply to culture wells.
Results"
Recovery of 3-OH iso C17:0 in organic extracts was evaluated using tooth
root slices before and after calculus removal. These results show 3-OH isoC17:o
recovery primarily in lipids of teeth and untreated root samples (58% and 67%,
respectively, of the total 3-OHisoC7:o ). Scaling of teeth reduced the percent
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recovery of 3-OHisoC17:o in lipid extracts (44% of the total 3-OHisoC17:o
recovered) (See Figure 2).
The results shown in Figure 3 demonstrate the recovery of 3-OHisoC17:o,
measured in ng/mm2, from root surfaces that are contaminated with calculus or
from cleaned root surfaces. Most but not all microbial lipids were removed by
scaling and root planing as described. The recovery of 3-OHisoC17:o in lipid
extracts from cleaned root sections was calculated to be 57.68 pg/mm2. This
value converts to 55.49 ng of 3-OHisoC7:0 added to each 35mm culture well
employed in further experimental trials, in order to achieve a concentration of
calculus- tooth lipid equal to that recovered on clean root surfaces. Given that
1.295 ng of 3-OHisoC7:o is recovered per ug of calculus-tooth lipid, this value
translates to 43 ug of calculus-tooth lipid/culture plated into each 35mm culture
well. In order to assess the effects of calculus-tooth lipid on gingival fibroblasts
at a level equivalent to cleaned root surfaces, 50 ug of calculus-tooth lipid was
placed into each culture well.
The mean recovery of 3-OHisoC7:0 in lipids from calculus-laden root
surfaces was 1,682 ng/mm2. The recovery of 3-OHisoC7:o in P.gingivalis lipids
was 22ng/ug, indicating that 74ug of lipid from P.gingivalis should be deposited
into each 35mm culture well in order to achieve the equivalent level of bacterial
lipid recovered on untreated root surfaces. For our present experiments
designed to evaluate P. gingivalis lipid effects on gingival fibroblasts, only 10ug
or 50ug aliquots of P. gingivalis lipid were plated into each 35mm culture well.
Experiment 3"
Using the average levels of bacterial lipid recovered from diseased root
surfaces of defined area, cultured fibroblasts were treated with calculus lipid at
a relevant concentration identified in goal 2. This allowed us to determine the
effect of the bacterial lipid on fibroblast secretory function and growth in culture.
We hypothesize that bacterial lipid applied at or below the concentration
defined by our previous study, will have a significant effect upon fibroblast cell
number and recovery. Additionally, a specific number of cell culture dishes will
be treated with L-1 beta, with and without the bacterial lipid.
Therefore, the goal of this study was to determine the effect of
calculus lipid on fibroblast secretory function and growth as
measured by recovered cells. We will determine the effect of calculus lipid
and P. gingivalis lipid, with and without IL-1 beta on fibroblast secretion of PGE2
The level of prostaglandin production by fibroblasts will be determined through
a prostaglandin extraction procedure. An increase in PGE2 production is
expected based upon our understanding of the production of PGE2 by
fibroblasts in the presence of disease, as well as the work of previous
investigators. At the end of each treatment, the cells will be released with
trypsin, thereby enabling us to assess the incorporation of calculus lipid, as
measured by the recovery of 3-OH C17:0 in extracted complex lipids. This study
will enable us to support our hypothesis, by demonstrating that lipids of
calculus promote secretory responses in gingival fibroblasts. This may prove
significant in the tissue destructive events that characterize and define
periodontitis.
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Materials and Methods"
Primary cultures of gingival fibroblasts were obtained using gingival
tissue explants harvested at the time of periodontal surgery. The explants were
initially placed in minimum essential medium (MEM) (Gibco, Grand Island, New
York) containing 10% fetal calf serum (Hyclone, Provo, Utah) and amphotericin
B (2.5ug/ml), penicillin G (1000 U/ml), and streptomycin (1 mg/ml), and
transported to the laboratory. The method used to culture fibroblasts is that
described by Richards and Rutherford in a 1988 publication. The explants were
placed in MEM and supplemented with 10% fetal calf serum, amphotericin B
(1.25 ug/ml), penicillin G (500U/ml), and streptomycin (500ug/ml) and minced
into small pieces. After cell monolayers had grown from the tissue explants, the
minced tissue pieces were aspirated from the culture dishes and the cell
monolayers grown to nearly confluence in MEM containing 10% fetal calf
serum, amphotericin B (0.25 ug/ml), penicillin G (100U/ml), and streptomycin
(100ug/ml). The cells were passaged using trypsin 0.1% in Ca, Mg-free
phosphate buffered saline and resuspended in MEM with 10% fetal calf serum,
penicillin G (100U/ml), streptomycin (100ug/ml) and amphotericin B (25ug/ml).
For all subsequent passaging of cells, fibroblasts were diluted approximately
1:4 with each passage and were subcultured for approximately ten passages
before starting fresh primary cultures. Cells were cultured in an H20 saturated,
5% CO2 atmosphere at 37 C.
Primary cultures of gingival fibroblasts were prepared from healthy
gingival tissue samples. The effects of P. gingivalis and calculus- tooth lipids
were assessed using the respective lipid extracts, at the levels defined in our
previous experiments, plated directly into 35mm culture wells and allowed to
dry. Control wells were treated with ethanol vehicle. Gingival fibroblasts were
inoculated onto the lipid films and allowed to grow for 7 days, exchanging old
medium with fresh medium at 3 day intervals. At seven days, the culture
medium was supplemented with human recombinant interleukin-1 beta
(Immunex Corporation, Seattle, A) to achieve a final concentration of 10 ng/ml.
Culture supernatants were collected after 48 hours of cytokine treatment and
prostaglandin levels determined in the medium samples by gas
chromatography- mass spectrometry. The adherent cells were released from
culture dishes with trypsin 0.1% in Ca, Mg-free phosphate buffered saline
(2ml/well). Each culture dish was then rinsed with an additional 2 ml of
phosphate buffered saline and pooled with the original washing. In order to
determine cell recovery, an aliquot of the cell suspension was counted
electronically (Coulter Counter) and the cells were centrifuged (1000 x g for 5
min.). The pelleted cells were frozen until lipid extraction and analysis of
bacterial fatty acid recovery in fibroblast lipid extracts.
Quantification of prostaglandin levels in medium samples"
Prostaglandin levels in fibroblast culture medium samples were
determined using gas chromatography- mass spectrometry. The thawed
medium samples were supplemented with 100ul of D4-PGF2alpha and D4-
PGE2 (approximately 500 ng/sample of gingiva, Cayman Chemical Co.). The
filtrates were adjusted to pH 3.5 with formic acid by adding approximately 100
ul/ml of concentrated formic acid. Reverse phase C-18 columns (Supelcoclean,
Supelco, Bellefonte, PA) were regenerated by first eluting 3 ml of 100%
methanol followed by 3 ml of PBS (pH 3.5). The acidified medium samples
were then eluted over the regenerated C-18 columns. The columns were then
washed with 3ml of 25% methanol in water and the prostaglandins were
recovered by eluting 3 ml of 100% methanol. Recovered prostaglandin samples
were then supplemented with 3 ml of 1% formic acid and extracted with CHCI3
(3 x 2ml). The organic solvent extracts were dried under nitrogen.
As previously described, all derivatizing agents were obtained from
Pierce Chemical Corp., Rockville, IL. Prostaglandin samples were derivatized
using the method of Waddell et al. (46). Eicosanoid samples were first treated
with 2% methoxylamine hydrochloride in pyridine (50 ul). After standing
overnight, the samples were dried under nitrogen, dissolved in acetonitrile (30
ul) and treated with pentafluorobenzyl bromide (35% v/v in acetonitrile, 10ul)
and diisopropylethylamine (10ul). The samples were vortexed, incubated for 20
minutes at 40oc and evaporated under nitrogen gas. The residue was then
treated with bistrimethylsilyl-trifluoroacetamide (BSTFA, 50ul) and allowed to
stand for 4-5 days. Hydroxy fatty acids were derivatized for gas
chromatography-mass spectrometry as described in earlier methods and
materials.
Derivatized products of hydroxy fatty acids and prostaglandins were then
transferred to vials used for GC-MS automated sampling (crimp cap vials, 200
ui). Prostaglandin derivatives in BSTFA were diluted 1"1 (v/v) with hexane
when transferred to the automatic sampling vials whereas the hydroxy fatty acid
derivatives were transferred without dilution. Derivatized prostanoid samples
frequently formed precipitates when transferred to the GC-MS vials. If carried
with the liquid sample into the gas chromatograph, the precipitate could
interfere with gas flow through the capillary column. This problem was avoided
by vortexing the samples and centrifuging at 2,000 rpm for 10 minutes. The
liquid supernatant was then aspirated and transferred to a new crimp cap vial.
Gas chromatography-mass spectrometry was carried out for
prostaglandins on a Hewlett Packard 5890-gas chromatograph interfaced with
a 9988A-mass spectrometer. Samples were applied to an HP-1 (Ultra-I, 12 m x
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0.2 mm, Hewlett Packard) column held at 100oc. Hydroxy fatty acid samples
were injected in the splitless mode (30 sec) and the column heated at 10OC/min
to 200oc followed by 2OC/min to 270oc. Prostanoid samples were analyzed
using a temperature program of 2OC/min from 100oc to 240oc. The injector
block was held at 260oc. The mass spectrometer was used in the negative ion-
chemical ionization mode with the source temperature at 100oc, the electron
energy at 240 eV and the emission current of 300 mA. Methane was used as
the analyte gas and was maintained at 0.5 torr in the ion source. Product levels
were quantified using selected ion monitoring of the characteristic base peak
ions for prostanoids and hydroxy fatty acids. The recovered prostanoid and
hydroxy fatty acid levels were normalized based on the tissue sample mass.
Recovery of OH fatty acid in gingival fibroblasts
Hydroxy fatty acid analysis by gas chromatography-mass
spectrometry: The dried fatty acid extracts were dissolved in acetonitrile (30ul) and
treated with 35% pentafluorobenzylbromide in acetonitrile (10ul) and
diisopropylethylamine (10ul). The solution was then heated for 20 min at 40oC and
evaporated to dryness under N2 gas. The resultant pentafluorobenzyl esters were
then treated with N,O-bis(trimethylsilyl)-trifluoroacetamide (50ul) and incubated
overnight. The lipid derivatives were applied to a Hewlett Packard 5890-gas
chromatograph interfaced with a 5988A-mass spectrometer. Samples were applied
to an Ultra-1 column (12 m x 0.2 mm, Hewlett Packard, Avondale, PA) held at 100C.
Samples will be injected using the splitless mode and a temperature program of
2C/min to 240oC. The mass spectrometer was used in the negative ion-chemical
ionization mode with the ion source temperature of 100C, the electron energy of 240
eV and an emission current of 300 mA. Methane is used as the reagent gas at 0.75
torr. Quantification of hydroxy-fatty acids from biological samples was accomplished
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using selected ion monitoring of the appropriate base peak ions of hydroxy fatty acids
and extraction losses were corrected using the recovery of the C19:0 internal standard.
Known amounts of 2-hydroxy-C4:o,-C16:o and
-C8:o and 3-hydroxy C14"0,-
C16:0,-iC17:0 and
-O18:0 (Matreya, Inc.) were analyzed for characteristic spectra,
selected base-peak ion retention times and signal responses relative to the C19"0
internal standard. The base peak ion for each fatty acid constitutes 60-80% of the total
ion abundance detected for each fatty acid standard and accounts in large part for the
very high sensitivity of this mass spectrometric technique. Derivatives of each hydroxy
fatty acid standard were individually applied to the GC-MS and the resultant fatty acid
peak was evaluated in the total ion scan mode (50-800 m/z, dwell time: 10
milliseconds) for its characteristic mass spectral pattern. The base peak ion for each
hylroxy fatty acid derivative was determined from the total ion mass spectra and for
these products, the base peak ion corresponded to the (M-PFB)-ion of each hydroxy
fatty acid. The hydroxy fatty acids derivatives were then run in the selected ion mode
and the retention times for each base peak ion were determined. The elution program
and mass spectrometer parameters, are described above. The C19:0 represents the
internal standard, a fatty acid which is not recovered from either bacterial or human
cells. The results demonstrated the characteristics of the pentafluorobenzyl-ester form
of O19:0, which is the final derivatized form of this fatty acid after the processing
described above. Detection limits for these substances are in the low picogram
range. Furthermore, alkaline or acid hydrolysis does not cause measurable
degradation of hydroxy fatty acid standards (data not shown).
Results
Recovery of Fibroblasts after treatment with Interleukin-1 with or
without bacterial lipid
Figure 4 demonstrates the recovery of gingival fibroblasts from culture
dishes following treatment with 1% trypsin in PBS (w/v). Cells were harvested
after 48 hours of exposure to interleukin-lbeta alone, or interleukin-lbeta
combined with P. gingivalis lipid or calculus-tooth lipid. When compared with
cells treated with interleukin-lbeta alone, fibroblast cell growth was inhibited by
approximately 50% when cells were exposed to P. gingivalis lipid (50ug
lipid/culture well) together with interleukin-lbeta. In addition, fibroblast cell
growth was inhibited with calculus-tooth lipid plus interleukin-lbeta by
approximately 20%. However, this difference was not statistically significant.
Recovery of Hydroxy Fatty Acids in lipid extracts of Gingival
Fibroblasts
Figure 5 demonstrates the recovery of 3-OHisoC7:o in lipid extracts of
gingival fibroblasts following harvesting the cells with 1% trypsin in PBS (w/v).
Recovery of 3-OHisoC7:o in gingival fibroblasts treated with 50ug of
P.gingivalis lipid plus interleukin-lbeta was significantly elevated when
compared to control cultures treated with interleukin-lbeta alone. The recovery
of P. gingivalis lipid in cells represented approximately 10% of the bacterial
lipid that was originally placed into the culture well based on the recovery of 3-
OHisoC17:o in the harvested cells. The recovery of 3-OHisoC17:o in lipid extracts
of fibroblasts treated with calculus lipid plus interleukin-lbeta was also
elevated. However, the recovery of calculus lipid in the fibroblasts represented
approximately 50% of the original bacterial lipid deposited into the culture wells
based on the recovery of 3-OHisoC17:o in fibroblast lipid extracts.
Prostaglandin release from gingival fibroblasts in culture
treated with interleukin-1 beta
Figure 6 demonstrates the effect of 10ug of P. gingivalis lipid on
interleukin-lbeta mediated prostaglandin secretion from fibroblast cells. Control
fibroblasts and those exposed to 10ug of P. gingivalis lipid secreted negligible
amounts of prostaglandin 52. Additionally, 50ug of P. gingivalis lipid did not
stimulate secretion of prostaglandin E2 from fibroblasts. However, with exposure
of fibroblasts to 10ng/ml of human recombinant interleukin-lbeta, a dramatic
increase in prostaglandin E2 secretion was observed. Furthermore, following
cell exposure to 10 ug of bacterial lipid plus interleukin-lbeta, prostaglandin
E2 secretion increased by an additional 15%.
Figure 7 demonstrates the effects of P. gingivalis lipid or calculus-tooth
lipid on interleukin-lbeta-mediated secretion of prostaglandin 52 and F2aipha
from fibroblasts.Gingival fibroblasts treated with 50ug of P. gingivalis lipid
extract plus 10ng/ml of interleukin-1 beta secreted three times more
prostaglandin 52 and F2alpha than those cells treated with interleukin-lbeta
alone. Fibroblasts treated with 50ug of calculus-tooth lipid plus interleukin-
1beta also secreted three times more prostaglandin E2 than cells treated with
interleukin-lbeta alone. While the effect on prostaglandin F2alpha was positive it
was not statistically significant.
General Discussion"
The experiments described herein demonstrate the recovery of bacterial
lipid containing 3-OH iSO017:0 on diseased root surfaces before and after
scaling and root planing. Given an understanding of the proximity and
biological inter-relationship between tooth root surfaces and adjacent
periodontal soft tissues, the present investigation demonstrated that such lipids
are capable of substantially potentiating L-1 beta-mediated secretion of
prostaglandin from gingival fibroblasts. This increased level of prostaglandin
secretion from gingival fibroblasts may in turn promote disease expression. The
preceding experimental trials may also define an important mechanism,
previously overlooked, by which periodontal pathogens alter host responses
perhaps to the extent that destructive periodontal disease is expressed.
Furthermore, while establishing a role for 3-OH isoC7:0- containing lipids in the
pathogenesis of periodontitis, the previously accepted theory of LPS and
periodontal disease causation is brought into question.
The recovery of the bacterial hydroxy fatty acid, 3-OH isoC17:o, in organic
and aqueous solvent extracts of plaque samples, teeth, and root sections
provided an indirect measure of bacterial complex lipid and lipopolysaccharide
levels, respectively [56]. The bacterial hydroxy fatty acid, 3-OHisoC7.0, is
recovered only in Porphyromonas, Prevotella, Bacteroides, Capnocytophaga
[90, 91], Fiavobacterium and Myxobacteria genera, but is not synthesized by
mammalian tissues. Flavobacterium and Myxobacteria are not reported to be
constituent organisms of subgingival plaque and the recovery of 3-OH isoC17:o
in organic and aqueous solvent extracts of plaque and gingival tissue samples
is presumed to reflect the recovery of Porphyromonas, Prevotella, Bacteroides
and Capnocytophaga species only [56]. Therefore, recovery of 3-OHisoC7:o in
gingival lipids is presumed to represent penetration of particular bacterial lipids
into the tissue under examination.
The present investigation employed aqueous and organic solvent
partitioning techniques in order to quantify hydroxy fatty acids recovered from
teeth, corresponding plaque samples and root sections before and after scaling
and root planing. The procedures employed would be expected to separate
bacterial lipids, recovered in the organic solvent phase, from LPS, which
remains in the aqueous phase. Assuming that bacterial hydroxy fatty acids are
not also synthesized in human tissues, the recovery of covalently linked hydroxy
fatty acids in aqueous and organic extracts of biological samples should
provide an indirect assessment of the quantity of bacterial LPS- and lipid-
associated hydroxy fatty acids. Given our understanding of the origin of 3-OH
/so017:0, its recovery in organic solvent and aqueous extracts of biological
samples should reflect the recovery of bacterial lipids or LPS, respectively, from
those organisms containing 3-OH/SO017:0 [56]. The present study demonstrated
that the majority of 3-OH/SO017:0 (--62% of the total in subgingival plaque
samples is recovered in the aqueous phase, most likely in lipopolysaccharide.
According to our study design, subgingival plaque samples were isolated from
periodontally-hopeless teeth immediately prior to tooth extraction. According to
Figure 1, approximately 58% of 3-OH isoC7:o from periodontally hopeless teeth
was recovered in lipid extracts. In addition, results from experimental trial 2
indicate that 67% of the total 3-OH/so017:0 recovered from root samples with
visible calculus was recovered in lipid extracts. In contrast, 58% of the total 3-
OH/so017:0 in P.gingivalis, was recovered in organic solvent extract. According
to Nichols (unpublished data), Prevotella, Bacteroides, and Capnocytophaga
generally incorporate 3-OH isoC17:o into lipids to a lesser degree than P.
gingivalis. Therefore, if tooth roots were contaminated with P. gingivalis only,
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the recovery of 3-OH iso017:0 would not be greater than 58% of the total [56].
Given that 3-OH /SO017:0 is recovered in lipid extracts of calculus contaminated
root surfaces to a greater degree than that recovered in both plaque samples
and P. gingivalis, these results support the argument that bacterial lipids
containing 3-OH/so017:0 are selectively adsorbed to tooth root surfaces and
may be concentrated in or on subgingival calculus deposits. A process of
selective adsorption may account for the elevated recovery of 3-OH/SO017:0 on
root surface lipids when compared with 3-OH isoC17:o containing lipid in
plaque.
As noted, 67% of the total 3-OH/SO017:0 recovered from root samples
with visible calculus present was recovered in lipid extracts. Given the
predominant recovery in lipid, one may argue that 3-OH isoC17:0 has a
propensity for mineralized tissue. Similarly, the preferential adsorption of
bacterial lipid to root surfaces may be related to the release of complex lipid
from bacterial cell walls through cell death, cell degradative processes, or cell
membrane modification. With regard to gingival tissue samples, 3-OH isoC17:o
is recovered virtually only in organic extracts, with negligible levels noted in
aqueous extract. Bacterial LPS is therefore either destroyed, cleared or fails to
enter gingival tissues. Furthermore, if LPS is not present in gingival tissues, the
organisms synthesizing 3-OH isoC17:o are likely not present as well [56].
Unpublished data demonstrates that at least 80% of 3-OH isoC17:o
present in gingival tissue is recovered in the subjacent connective tissue lipids.
This would indicate that bacterial lipids containing 3-OH isoC17:o penetrate into
gingival connective tissue through overlying epithelium. Additional research is
needed to investigate the possibility that these lipids, which selectively adsorb
to root surfaces and therefore appear to have an affinity for mineralized tissues,
may be capable of exerting effects on both cementum and bone. Should this be
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found to be true, it would have a substantial effect on our understanding of the
pathogenesis of the periodontal destructive lesion.
Given our understanding of the characteristics of periodontal disease as
described, as well as the apparent affinity of 3-OH iSO017:0 for mineralized
surfaces, one may suggest that root surfaces contaminated with bacterial lipids
can provide a reservoir of lipids for penetration into gingiva directly contacting
the root surface. Such a process would depend on the diffusion characteristics
of the lipids in host cell membranes and their diffusion potential on
contaminated root surfaces. The present investigation provides evidence to
support the notion of a lipid reservoir, by demonstrating that the lipids of P.
gingivalis and subgingival calculus are taken up by gingival fibroblasts, likely
through incorporation into the fibroblast cell membrane. Therefore, the present
study provides a model for investigating the incorporation of bacterial lipids into
host cells, as a possible explanation for bacterial lipid recovery in gingival
tissues without direct bacterial invasion.
It is known that diseased gingival tissues demonstrate elevated levels of
PGE2. Prostaglandins are considered to be important proinflammatory and
tissue destructive mediators. While many bacterial and host derived factors are
known to stimulate prostaglandin secretion from host cells in vitro, there is little
evidence demonstrating a direct correlation between bacteria and/or bacterial
factors and prostaglandin levels in tissue samples [83]. In the present study, the
primary objective was to assess and define the biological influence of complex
lipids on host cells, specifically their potentiation of fibroblast prostaglandin
secretion. The effects of bacterial lipids on fibroblast secretory function were
determined using lipid isolates from P. gingivalis or calculus contaminated-
teeth. Biologically relevant levels of lipid were determined by assessing
recovery of 3-OH/so017:0 on calculus contaminated root surfaces before and
after thorough scaling and root planing. The maximum amount of calculus-tooth
lipid deposited on culture dish surfaces was based on the level of 3-OH isoC7.o
recovered on cleaned tooth surfaces. In the present study, fibroblast growth was
inhibited and interleukin-lbeta-mediated prostaglandin secretion was
significantly stimulated, following application of calculus-tooth lipid to culture
dishes at a level approximating that recovered on cleaned root surfaces. In
addition, exposure of gingival fibroblasts to P. gingivalis lipid at a level below
that recovered on root surfaces contaminated with calculus, markedly interfered
with cell growth and resulted in significant stimulation of interleukin-1 beta-
mediated prostaglandin secretion. Finally, application of P. gingivafis lipid at a
level that is only slightly greater than the amount of 3-OH isoC17:o recovered on
cleaned root surfaces, resulted in slight stimulation of prostaglandin secretion
that was not statistically significant.
Significant changes in fibroblast secretory function following application
of both P. gingivalis lipid and calculus- tooth lipid, at the levels recovered on
cleaned root surfaces, provide support for a new paradigm regarding
periodontal disease pathogenesis. The lipid extract from calculus contaminated
root surfaces was more potent than the lipid extract from P. gingivalis (based on
the levels of 3-OHisoC7:o per unit mass of lipid applied to culture dishes). In
order to further support a hypothesis regarding the influence of bacterial
hydroxy fatty acids on fibroblast cell recovery and prostaglandin secretory
function, we completed an assessment of the uptake of 3-OH isoC7:o in
fibroblast lipids after treatment with interleukin 1-beta. Following completion of
the culture period, we noted that only 10% of the P. gingivalis lipid plated onto
culture dishes was recovered in fibroblasts, while 50% of the 3-OH isoC7:o-
containing lipid in calculus-tooth lipid was recovered in fibroblasts. Therefore,
the bacterial lipids containing 3-OH isoC7:o recovered in calculus-tooth lipid
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extract, possess a greater capacity for incorporation into gingivai fibroblasts.
More importantly, this may account for the strength of the biological influence
noted.
Summary and Conclusions:
Periodontal disease is influenced by a host of risk factors that we
continue to more accurately define. However, the intricacies of periodontal
disease pathogenesis remain a subject of continued research. The present
investigation demonstrated that bacterial lipids adsorbed to diseased root
surfaces can penetrate into gingival tissues and potentiate interleukin-1 beta-
mediated secretion of prostaglandins from gingival fibroblasts. Specifically, an
elevation in interleukin-1 beta associated with inflammatory periodontal lesions,
results in an increase in prostaglandin E2 levels more in the presence of P.
gingivalis and calculus-tooth lipid than in their absence. This finding may serve
as a basis for redefining the nature of periodontal disease pathogenesis. In
addition, the preceding experimental trials and results may have profound
implications regarding our understanding of the biology and treatment of
periodontal disease.
Until we discover the true pathogenesis of periodontitis, our ability to
predictably treat disease will remain limited. Is periodontal disease, or rather
adult periodontitis, a lipid disease? The findings of the present investigation
and the subsequent model developed, suggest that periodontal disease may be
significantly influenced by bacterial lipids.
In summary, the present investigation sought to define a role for hydroxy
fatty acid containing lipids, other than LPS, in the pathogenesis of periodontitis.
Specifically, we determined the recovery of bacterial lipids containing 3-OH
/so017:0 on diseased root surfaces before and after root planing and scaling.
The relevant lipid levels were then employed for exposure to gingival fibroblasts
in culture. The present study demonstrated that lipid extracts obtained from both
P. gingivalis or calculus-contaminated tooth surfaces are capable of
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significantly potentiating interleukin 1-beta secretory responses in gingival
fibroblasts. This may serve as a basis for further inquiry as we redefine
periodontal disease pathogenesis and the treatment of periodontal disease.
Figure 1
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Figure 3
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Figure 4
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Figure 5
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Figure 7
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